Investor Expectations to Drive Momentum within ZIOPHARM Oncology, MedEquities Realty Trust, Argan, Churchill Downs, Tyson Foods, and Acadia Realty Trust — Discovering Underlying Factors of Influence

Author's Avatar
Jun 29, 2018
Article's Main Image

NEW YORK, June 29, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ZIOPHARM Oncology Inc. (ZIOP, Financial), MedEquities Realty Trust Inc. (:MRT), Argan, Inc. (:AGX), Churchill Downs, Incorporated (CHDN, Financial), Tyson Foods, Inc. (:TSN), and Acadia Realty Trust (:AKR), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

ZIOP DOWNLOAD: http://Fundamental-Markets.com/register/?so=ZIOP
MRT DOWNLOAD: http://Fundamental-Markets.com/register/?so=MRT
AGX DOWNLOAD: http://Fundamental-Markets.com/register/?so=AGX
CHDN DOWNLOAD: http://Fundamental-Markets.com/register/?so=CHDN
TSN DOWNLOAD: http://Fundamental-Markets.com/register/?so=TSN
AKR DOWNLOAD: http://Fundamental-Markets.com/register/?so=AKR

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine ZIOPHARM Oncology Inc. (ZIOP, Financial), MedEquities Realty Trust Inc. (:MRT), Argan, Inc. (:AGX), Churchill Downs, Incorporated (CHDN, Financial), Tyson Foods, Inc. (:TSN), and Acadia Realty Trust (:AKR) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed June 27th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

ZIOPHARM ONCOLOGY INC. (ZIOP, Financial) REPORT OVERVIEW

ZIOPHARM Oncology's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, ZIOPHARM Oncology reported revenue of $0.15MM vs $1.60MM (down 90.86%) and basic earnings per share -$0.15 vs -$0.15. For the twelve months ended December 31st, 2017 vs December 31st, 2016, ZIOPHARM Oncology reported revenue of $6.39MM vs $6.86MM (down 6.88%) and basic earnings per share -$0.53 vs -$1.32. ZIOPHARM Oncology is expected to report earnings on July 30th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.13. The estimated EPS forecast for the next fiscal year is -$0.41 and is expected to report on March 7th, 2019.

To read the full ZIOPHARM Oncology Inc. (ZIOP, Financial) report, download it here: http://Fundamental-Markets.com/register/?so=ZIOP

-----------------------------------------

MEDEQUITIES REALTY TRUST INC. (MRT, Financial) REPORT OVERVIEW

MedEquities Realty Trust's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, MedEquities Realty Trust reported revenue of $16.72MM vs $14.28MM (up 17.04%) and basic earnings per share $0.16 vs $0.14 (up 14.29%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, MedEquities Realty Trust reported revenue of $61.11MM vs $49.30MM (up 23.96%) and basic earnings per share $0.64 vs -$0.18. MedEquities Realty Trust is expected to report earnings on August 14th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.27. The estimated EPS forecast for the next fiscal year is $1.25 and is expected to report on February 20th, 2019.

To read the full MedEquities Realty Trust Inc. (MRT, Financial) report, download it here: http://Fundamental-Markets.com/register/?so=MRT

-----------------------------------------

ARGAN, INC. (AGX, Financial) REPORT OVERVIEW

Argan's Recent Financial Performance

For the three months ended April 30th, 2018 vs April 30th, 2017, Argan reported revenue of $141.37MM vs $230.49MM (down 38.67%) and basic earnings per share $0.31 vs $1.33 (down 76.69%). For the twelve months ended January 31st, 2018 vs January 31st, 2017, Argan reported revenue of $892.82MM vs $675.05MM (up 32.26%) and basic earnings per share $4.64 vs $4.67 (down 0.64%). Argan is expected to report earnings on September 6th, 2018. The report will be for the fiscal period ending July 31st, 2018.

To read the full Argan, Inc. (AGX, Financial) report, download it here: http://Fundamental-Markets.com/register/?so=AGX

-----------------------------------------

CHURCHILL DOWNS, INCORPORATED (CHDN, Financial) REPORT OVERVIEW

Churchill Downs' Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Churchill Downs reported revenue of $189.30MM vs $167.50MM (up 13.01%) and basic earnings per share $12.61 vs $0.44 (up 2,765.91%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Churchill Downs reported revenue of $882.60MM vs $822.40MM (up 7.32%) and basic earnings per share $8.91 vs $6.52 (up 36.66%). Churchill Downs is expected to report earnings on July 25th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $4.81. The estimated EPS forecast for the next fiscal year is $13.01 and is expected to report on February 27th, 2019.

To read the full Churchill Downs, Incorporated (CHDN, Financial) report, download it here: http://Fundamental-Markets.com/register/?so=CHDN

-----------------------------------------

TYSON FOODS, INC. (TSN, Financial) REPORT OVERVIEW

Tyson Foods' Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Tyson Foods reported revenue of $9,773.00MM vs $9,083.00MM (up 7.60%) and basic earnings per share $0.86 vs $0.93 (down 7.53%). For the twelve months ended September 30th, 2017 vs September 30th, 2016, Tyson Foods reported revenue of $38,260.00MM vs $36,881.00MM (up 3.74%) and basic earnings per share $4.85 vs $4.59 (up 5.66%). Tyson Foods is expected to report earnings on August 6th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $1.28. The estimated EPS forecast for the next fiscal year is $6.92 and is expected to report on November 12th, 2018.

To read the full Tyson Foods, Inc. (TSN, Financial) report, download it here: http://Fundamental-Markets.com/register/?so=TSN

-----------------------------------------

ACADIA REALTY TRUST (AKR, Financial) REPORT OVERVIEW

Acadia Realty Trust's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Acadia Realty Trust reported revenue of $63.12MM vs $62.00MM (up 1.81%) and basic earnings per share $0.09 vs $0.18 (down 50.00%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Acadia Realty Trust reported revenue of $250.26MM vs $189.94MM (up 31.76%) and basic earnings per share $0.73 vs $0.94 (down 22.34%). Acadia Realty Trust is expected to report earnings on July 24th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.37. The estimated EPS forecast for the next fiscal year is $1.48 and is expected to report on February 20th, 2019.

To read the full Acadia Realty Trust (AKR, Financial) report, download it here: http://Fundamental-Markets.com/register/?so=AKR

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at [email protected].

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: [email protected]

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at [email protected].

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

ti?nf=NzMyMDc5MyMyMzg0MjYzIzUwMDAyNzg3MA==